Press ReleaseIB Communicationsautolomous@ibcomms.agency Adva Biotechnology and Autolomous Launch the Digital PIONEER Program to Enable Decentralized, Scalable Cell Therapy Manufacturing — GenCART Inc.
Update on US Green Card Regulations US Green Card Policy Update: The pathway to acquiring a US Green Card, which grants ...
Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
Final FDA Type C Meeting December 11, 2025 - biomarker data to be availableOctober 10, 2025 FDA/Osteosarcoma Institute ...
Cell culture is a fundamental technique in biotechnology and life sciences that involves growing and maintaining living cells outside their natural environment, typically in a controlled laboratory ...
The 2022 Option Agreement between Astellas and Taysha has expiredRegaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus ...
Antimicrobial resistance (AMR) represents one of the most pressing global health threats, surpassing mortality rates ...
The US Patent and Trademark Office will issue BIAF a new patent on its flow cytometry+AI platform that detects lung cancer as ...
Biotechnology research centers employ mushroom fermenters to study fungal physiology, genetics, and metabolite biosynthesis, ...
CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today ...
IIT Bombay has extended the registration deadline for JAM 2026 to October 20, 2025. This exam allows admission to MSc, MS, ...